Unique Wealth Strategies’s GSK GSK Stock Holding History

Unique Wealth Strategies’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-14,075	Closed	-$607K	–	241
2025 Q3	$607K	Buy	14,075 +668	+5%	+$26.1K	0.24%	135
2025 Q2	$515K	Buy	13,407 +6,146	+85%	+$235K	0.21%	146
2025 Q1	$281K	Buy	7,261 +43	+0.6%	+$1.57K	0.13%	166
2024 Q4	$244K	Buy	+7,218	New	+$260K	0.11%	178
2024 Q3	–	Sell	-2,262	Closed	-$97K	–	398
2024 Q2	$97K	Buy	+2,262	New	+$95.2K	0.05%	210

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Unique Wealth Strategies's GSK Position: Q4 2025 in Review

Unique Wealth Strategies sold out of GSK (GSK) in Q4 2025, closing a stake of 14,075 shares — an estimated $607K sold.

Unique Wealth Strategies first reported a position in GSK in Q2 2024 and held it in 5 quarters. The position peaked at $607K in Q3 2025. 995 funds tracked by Wall St. Rank hold GSK as of Q4 2025.

Unique Wealth Strategies reported no remaining GSK position as of Q4 2025 after selling out during the quarter.
Unique Wealth Strategies sold 14,075 GSK shares in Q4 2025, an estimated $607K.
Unique Wealth Strategies first reported a position in GSK in Q2 2024 and held it in 5 quarters.
Unique Wealth Strategies's GSK position peaked at $607K in Q3 2025.
995 funds tracked by Wall St. Rank held GSK as of Q4 2025.

Based on Unique Wealth Strategies's 13F filing for Q4 2025, filed 14 Jul 2026.